Cargando…
Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient
BACKGROUND: The factors determining differential HIV disease outcome among individuals expressing protective HLA alleles such as HLA-B*27:05 and HLA-B*57:01 remain unknown. We here analyse two HIV-infected subjects expressing both HLA-B*27:05 and HLA-B*57:01. One subject maintained low-to-undetectab...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771019/ https://www.ncbi.nlm.nih.gov/pubmed/29338738 http://dx.doi.org/10.1186/s12977-018-0390-9 |
_version_ | 1783293180640231424 |
---|---|
author | Brener, Jacqui Gall, Astrid Hurst, Jacob Batorsky, Rebecca Lavandier, Nora Chen, Fabian Edwards, Anne Bolton, Chrissy Dsouza, Reena Allen, Todd Pybus, Oliver G. Kellam, Paul Matthews, Philippa C. Goulder, Philip J. R. |
author_facet | Brener, Jacqui Gall, Astrid Hurst, Jacob Batorsky, Rebecca Lavandier, Nora Chen, Fabian Edwards, Anne Bolton, Chrissy Dsouza, Reena Allen, Todd Pybus, Oliver G. Kellam, Paul Matthews, Philippa C. Goulder, Philip J. R. |
author_sort | Brener, Jacqui |
collection | PubMed |
description | BACKGROUND: The factors determining differential HIV disease outcome among individuals expressing protective HLA alleles such as HLA-B*27:05 and HLA-B*57:01 remain unknown. We here analyse two HIV-infected subjects expressing both HLA-B*27:05 and HLA-B*57:01. One subject maintained low-to-undetectable viral loads for more than a decade of follow up. The other progressed to AIDS in < 3 years. RESULTS: The rapid progressor was the recipient within a known transmission pair, enabling virus sequences to be tracked from transmission. Progression was associated with a 12% Gag sequence change and 26% Nef sequence change at the amino acid level within 2 years. Although next generation sequencing from early timepoints indicated that multiple CD8+ cytotoxic T lymphocyte (CTL) escape mutants were being selected prior to superinfection, < 4% of the amino acid changes arising from superinfection could be ascribed to CTL escape. Analysis of an HLA-B*27:05/B*57:01 non-progressor, in contrast, demonstrated minimal virus sequence diversification (1.1% Gag amino acid sequence change over 10 years), and dominant HIV-specific CTL responses previously shown to be effective in control of viraemia were maintained. Clonal sequencing demonstrated that escape variants were generated within the non-progressor, but in many cases were not selected. In the rapid progressor, progression occurred despite substantial reductions in viral replicative capacity (VRC), and non-progression in the elite controller despite relatively high VRC. CONCLUSIONS: These data are consistent with previous studies demonstrating rapid progression in association with superinfection and that rapid disease progression can occur despite the relatively the low VRC that is typically observed in the setting of multiple CTL escape mutants. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12977-018-0390-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5771019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57710192018-01-25 Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient Brener, Jacqui Gall, Astrid Hurst, Jacob Batorsky, Rebecca Lavandier, Nora Chen, Fabian Edwards, Anne Bolton, Chrissy Dsouza, Reena Allen, Todd Pybus, Oliver G. Kellam, Paul Matthews, Philippa C. Goulder, Philip J. R. Retrovirology Research BACKGROUND: The factors determining differential HIV disease outcome among individuals expressing protective HLA alleles such as HLA-B*27:05 and HLA-B*57:01 remain unknown. We here analyse two HIV-infected subjects expressing both HLA-B*27:05 and HLA-B*57:01. One subject maintained low-to-undetectable viral loads for more than a decade of follow up. The other progressed to AIDS in < 3 years. RESULTS: The rapid progressor was the recipient within a known transmission pair, enabling virus sequences to be tracked from transmission. Progression was associated with a 12% Gag sequence change and 26% Nef sequence change at the amino acid level within 2 years. Although next generation sequencing from early timepoints indicated that multiple CD8+ cytotoxic T lymphocyte (CTL) escape mutants were being selected prior to superinfection, < 4% of the amino acid changes arising from superinfection could be ascribed to CTL escape. Analysis of an HLA-B*27:05/B*57:01 non-progressor, in contrast, demonstrated minimal virus sequence diversification (1.1% Gag amino acid sequence change over 10 years), and dominant HIV-specific CTL responses previously shown to be effective in control of viraemia were maintained. Clonal sequencing demonstrated that escape variants were generated within the non-progressor, but in many cases were not selected. In the rapid progressor, progression occurred despite substantial reductions in viral replicative capacity (VRC), and non-progression in the elite controller despite relatively high VRC. CONCLUSIONS: These data are consistent with previous studies demonstrating rapid progression in association with superinfection and that rapid disease progression can occur despite the relatively the low VRC that is typically observed in the setting of multiple CTL escape mutants. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12977-018-0390-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-16 /pmc/articles/PMC5771019/ /pubmed/29338738 http://dx.doi.org/10.1186/s12977-018-0390-9 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Brener, Jacqui Gall, Astrid Hurst, Jacob Batorsky, Rebecca Lavandier, Nora Chen, Fabian Edwards, Anne Bolton, Chrissy Dsouza, Reena Allen, Todd Pybus, Oliver G. Kellam, Paul Matthews, Philippa C. Goulder, Philip J. R. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient |
title | Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient |
title_full | Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient |
title_fullStr | Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient |
title_full_unstemmed | Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient |
title_short | Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient |
title_sort | rapid hiv disease progression following superinfection in an hla-b*27:05/b*57:01-positive transmission recipient |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771019/ https://www.ncbi.nlm.nih.gov/pubmed/29338738 http://dx.doi.org/10.1186/s12977-018-0390-9 |
work_keys_str_mv | AT brenerjacqui rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT gallastrid rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT hurstjacob rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT batorskyrebecca rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT lavandiernora rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT chenfabian rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT edwardsanne rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT boltonchrissy rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT dsouzareena rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT allentodd rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT pybusoliverg rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT kellampaul rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT matthewsphilippac rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient AT goulderphilipjr rapidhivdiseaseprogressionfollowingsuperinfectioninanhlab2705b5701positivetransmissionrecipient |